IMARC Group's report titled “Pressure Ulcers Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, offers a comprehensive analysis of the industry, which comprises insights on the global pressure ulcers treatment market report. The global market size reached US$ 5.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.9 Billion by 2028, exhibiting a growth rate (CAGR) of 5.18% during 2023-2028.
Pressure ulcers, also called as bedsores, are caused by prolonged pressure and shearing forces on the skin, resulting in degenerative injuries to both the skin and underlying tissues. They generally affect the body with bony and muscle structures, including the back, buttocks, tailbone, heels, elbow, shoulder, and ankles. Pressure ulcers lead to morbidity and mortality, especially among consumers with impaired sensation, poor nutrition, comorbidities, and prolonged immobility. Their treatment involves preventive measures and medications that aid in averting the formation of deep craters exposing muscle and bone. Additionally, early identification and treatment of this disorder play a crucial role in minimizing complications.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/pressure-ulcers-treatment-market/requestsample
Pressure Ulcers Treatment MarketTrends and Drivers:
The expanding global geriatric population, which is more susceptible to developing these ulcers, on account of skin fragility, thinning of cell layers, decreased capillary density, and impaired cell growth, is primarily driving the pressure ulcers treatment market. Furthermore, the growing prevalence of obesity and chronic medical conditions, such as bone and joint infections, cellulitis, sepsis, and cancer, is also augmenting the market growth. Apart from this, the increasing awareness in the masses about the early diagnosis of bedsores and the easy availability of treatment are positively influencing the global market. Moreover, the expansion of hospitals, clinics, pharmacies, and drug stores and the introduction of technological advancements in the healthcare industry are further bolstering the market growth. Besides this, the rising focus of leading market players on the formulation of novel wound care products is expected to drive the pressure ulcers treatment market in the coming years.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Ulcer Type:
- Stage 1
- Stage 2
- Stage 3
- Stage 4
Breakup by Product Type:
- Wound-Care Dressings
- Wound-Care Devices
- Others
Breakup by End User:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Homecare Settings
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- 3M Company
- Arjo AB
- Braun Melsungen AG (B. Braun Holding GmbH & Co. KG)
- Cardinal Health Inc.
- Coloplast A/S
- Hill-Rom Holdings Inc. (Baxter International Inc.)
- Invacare Corporation
- Mölnlycke Health Care AB
- Smith & Nephew plc
- Span America (UTi Worldwide Inc.)
- Stiegelmeyer GmbH & Co. KG and Stryker Corporation
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
Comments